Boehringer Ingelheim Pty Limited ("BIPL") is bound by the Australian Privacy Principles ("APPs") and adheres to these Principles. The personal information BIPL collects from you when you access and use the Pradaxa App will be used for the purpose of enabling you to access and use the Pradaxa App and to provide you with other educational and promotional communications we think may be of interest to you ("this purpose"). If you do not provide all or some of the requested personal information to us, we may not be able to provide you with access to the Pradaxa App and we may not be able to keep you up-to-date with educational and promotional information we think may be of interest to you. We may disclose your personal information to third party contractors who we engage to assist us with this purpose. We keep your personal information in secure databases that may be hosted on servers that are located outside of Australia (such as in the USA, Japan, Singapore and Germany), in which case we may disclose your personal information to those overseas hosting providers for that purpose only. We may also disclose your personal information to any entity within the worldwide group of Boehringer Ingelheim companies some of which are located outside of Australia including but not limited to New Zealand, Germany and the USA. Our Privacy Policy (at https://www.boehringer-ingelheim.com.au/data-privacy) contains information about how you can access and request the correction of your personal information, how you can make a complaint about a breach of the APPs and how we will deal with your complaint. You can contact BIPL or our Privacy Officer by email at privacyofficer.syd@boehringer-ingelheim.com or on +(61)(2) 8875 8800.
Boehringer Ingelheim Pty. Ltd. ACN: 000 452 308 (Level 1. 78 Waterloo Road, North Ryde, New South Wales 2113, Australia);
Boehringer Ingelheim (N.Z.) Limited NZCN: 88986 (Level 3, 2 Osterley Way, Manukau, Auckland 2104, New Zealand) and
Boehringer Ingelheim Animal Health Australia Pty. Ltd. ACN: 071 187 285 (Level 1, 78 Waterloo Road, North Ryde, New South Wales 2113, Australia); and
Boehringer Ingelheim Animal Health New Zealand Limited NZCN: 664734 (Level 3, 2 Osterley Way, Manukau, Auckland 2104, New Zealand)
each of which is a part of the worldwide group of Boehringer Ingelheim companies (collectively referred to as Boehringer Ingelheim, we, our and us) are bound by and comply with, in Australia, the Privacy Act 1988 (Cth) and the Australian Privacy Principles (APPs), and in New Zealand, the Privacy Act 1993 (N.Z) and the New Zealand Information Privacy Principles (IPPs) (as applicable).
Boehringer Ingelheim respects individual privacy and the rights of individuals to control their personal information. Boehringer Ingelheim and our third party contractors are bound by privacy laws in respect of the collection, use, disclosure and handling of your personal information.
Boehringer Ingelheim recognises the importance of your privacy and understands that the security of your personal information is important to you. We are committed to protecting the personal information you provide to us and which we collect from you. This Privacy Policy sets out the basis on which Boehringer Ingelheim collects personal information and also the basis on which any such personal information will be dealt with.
Types of information collected and held
"Personal information" is information or an opinion about an identified individual, or an individual who is identifiable: whether or not the information or opinion is true and whether or not the information is recorded in a material form.
Boehringer Ingelheim collects and processes personal information about you for a lawful purpose connected with our functions or activities and the collection of the information is reasonably necessary for us to perform our functions and activities, including providing the best possible quality of customer service to you.
Wherever it is practical, Boehringer Ingelheim will only collect your personal information where you have provided it to us voluntarily and knowingly. This means you are under no obligation to provide personal information to us, although a failure to provide all or some of the requested personal information in some circumstances may limit our ability to provide products, services or information to you or otherwise to do business with you.
While you are under no obligation to provide personal information to us, a failure to provide all or some of the requested personal information in some circumstances may limit our ability to provide products, services or information to you or otherwise to do business with you.
The types of personal information that we collect includes:
your name, email address and other contact details;
any questions or comments that you may post;
information about you in relation to the goods and services we provide;
if you are visiting our websites, the IP address of your machine when connected to the internet and the domain name from which you are accessing the internet; and
if you are a healthcare professional, veterinary clinic personnel or a Boehringer Ingelheim third party contractor, we may collect your professional details (including but not limited to your curriculum vitae, qualifications, education and training records), your business details and details of the interaction we have with you.
Boehringer Ingelheim may collect other types of personal information where it is necessary for us to take appropriate action in relation to a reasonable suspicion of unlawful activity or misconduct of a serious nature, that relates to our functions or activities.
Clinical trials
If you are a participant to a research study, the types of information collected, the purpose for collection and additional information on how we treat your data is explained to you during the informed consent process.
Sensitive information
We may collect information that is considered "sensitive information" in Australia, such as information about your state of health and medical history.
How we collect and hold personal information
Boehringer Ingelheim collects your personal information that you voluntarily and knowingly provide when:
you purchase one of our products and you apply for a credit account with us;
you access any of our websites;
you subscribe to our social media accounts including those on Twitter and Facebook;
you contact Boehringer Ingelheim in order to make an enquiry about Boehringer Ingelheim or a particular Boehringer Ingelheim product;
you participate in a Boehringer Ingelheim non-prescription product survey or promotion;
you attend one of our conference meetings or events;
you participate in a Boehringer Ingelheim sponsored program (including but not limited to research study, compassionate use program, product familiarization program, patient support program, educational program, disease management program) as either a healthcare professional, a Boehringer Ingelheim third party contractor or a participant.
Boehringer Ingelheim will usually only collect personal information directly from you. We may also collect personal information from third parties (where is is unreasonable or impractical to collect personal information from you directly or where you have authorised collection from such third parties) or from publicly available resources.
From time to time the collection and processing of personal information is carried out by our third party contractors, third party data suppliers, recruitment agencies etc. When your personal information is collected by external third parties, we will take reasonable measures to ensure that those third parties are aware of and comply with this Privacy Policy.
Boehringer Ingelheim takes reasonable steps to ensure that all personal information is kept secure in accordance with reasonable physical, electronic, and managerial procedures. However, for personal information collected online and stored in electronic databases, you acknowledge that no security system is impenetrable and that the security of those databases can never be guaranteed. Boehringer Ingelheim also cannot guarantee that the information you supply will not be intercepted while being transmitted over the internet. Accordingly, any personal information or other information which you transmit to us is transmitted at your own risk. Nevertheless, once we receive your transmission, we will take reasonable steps to preserve the security of such information and ensure that there are appropriate security protections in place.
Subject to applicable privacy laws, if your personal information is no longer needed for any purpose for which it was collected or for which it may be lawfully used, we will either destroy it or permanently anonymise it.
Purpose for which we collect, hold, use and disclose your personal information
Boehringer Ingelheim will collect, hold, use and disclose your personal information only for the purpose for which you provide it to us. We will not use or disclose personal information about you for any secondary purpose, unless you consent to that use or disclosure, or:
if in Australia, you would reasonably expect the use or disclosure in the circumstances, and that secondary purpose is:
in the case of non-sensitive information: related to the primary purpose for which we have collected that information, and
in the case of sensitive information: directly related to the primary purpose; or
2. if in New Zealand, that secondary purpose is directly related to the primary purpose.
Furthermore, your personal information will not be shared, sold, rented or otherwise used or disclosed outside the Boehringer Ingelheim group of companies (except as required for any statutory or legal requirements) in ways different from what is described in this Privacy Policy.
The purposes for which Boehringer Ingelheim may use or disclose your personal information include:
to provide you with any services or goods that you may request;
to provide you with information in relation to educational materials, educational events and products in a field you have indicated is of interest to you or we think may be of interest to you;
to respond to any query or complaint that you may make;
to involve health professionals and investigators (and people who assist them) in clinical trials;
for internal administration, product research, evaluation and development, and quality control purposes,
for other purposes to which you have consented; and
for any other purposes required or authorised by law or a court/tribunal order or by a regulatory body.
Boehringer Ingelheim may disclose personal information it collects about you to:
any entity within the group of Boehringer Ingelheim entities (within and outside of Australia and New Zealand);
>third parties within or outside of Australia and New Zealand engaged to help Boehringer Ingelheim improve its pharmaceutical products;
third party contractors engaged to perform functions to provide services relating to the purposes for which we collect personal information as set out in this Privacy Policy.
enforcement authorities and regulatory bodies, within and outside of Australia and New Zealand, and ethics committees as part of a clinical trial evaluation, monitoring and inspection process;
any other parties it deems necessary in relation to providing you access to the Website.
We will take reasonable steps to ensure that any organisations we disclose your presonal information to, whether local or overseas, safeguard and protect your personal information and compy with privacy laws.
Boehringer Ingelheim may combine any information which it collects from you with information collected by any entity within the group of Boehringer Ingelheim entities or any third party contractors or service providers engaged to perform functions or provide services relating to the purposes for which we collect your personal information.
Access to and correction of Personal Information
Boehringer Ingelheim will take all reasonable steps to ensure any personal information we collect is up-to-date, complete and accurate. We will also take reasonable steps to ensure that any personal information that we use or disclose is up-to-date, complete, accurate, relevant and not misleading.
You have the right to request access to the personal information we hold about you, or request that your personal information be corrected if you believe for any reason that the information we hold is inaccurate, incomplete, not accurate or up to date, or misleading, or in Australia ask for your personal information to be removed if you no longer wish Boehringer Ingelheim to keep your personal information on file.
Boehringer Ingelheim will take reasonable steps to provide a way to correct, update or remove your records. Boehringer Ingelheim may charge you a small fee to cover any reasonable administrative costs that we incur in providing you with access to your personal information. We will facilitate access (including through the use of an intermediary if necessary) unless we are required or authorised under any relevant law or court/tribunal order to withhold access. You can obtain further information about how to request access to or correct the information held about you by Boehringer Ingelheim by contacting our Privacy Officer:
Postal address: The Privacy Officer. PO Box 1969, Macquarie Centre NSW 2113
Telephone: + (61) (2) 8875 8800
Fax: + (61) (2) 8875 8801
If you consider a breach of the APPs or the IPPs has occurred, you may direct your query to our Privacy Officer in the first instance at privacyofficer.syd@boehringer-ingelheim.com. We may require you to put your complaint in writing.
Our Privacy Officer will investigate the issue and take steps (if any) to resolve your complaint, and will notify you in writing of the outcome of the investigation. If you do not consider our response satisfactory, you may contact us to discuss your concerns or contact the Australian Privacy Commissioner at its website www.oaic.gov.au or the Office of the Privacy Commissioner in New Zealand (as applicable) at www.privacy.org.nz.
Overseas disclosures
We may, in the course of providing products and services to you, disclose personal information to overseas entities (including our group companies which are located overseas including but not limited to Singapore, USA and Germany) and external data processors/web hosting servers located outside of Australia and New Zealand (such as in the USA, Japan, Singapore and Germany).
The types of personal information that we are likely to disclose to overseas entities include your name, email, address, de-identified sensitive information, information about you relating to the services and goods we provide you, professional and business details and/or information related to adverse events related to our products.
You acknowledge that where personal information is disclosed to entities in the countries above:
the Privacy Act 1988 (Cth) and the Privacy Act 1993 (N.Z) may not apply; and
applicable laws in those countries (which may not provide comparable safeguards to those in the Privacy Act 1988 (Cth) and the Privacy Act 1993 (N.Z) may apply, to the collection, use, storage and processing of that information by those entities in those countries.
Changes to our Privacy Policy
This is our current Privacy Policy and replaces any other privacy policy previously published by us. We may vary this Privacy Policy from time to time. If we make changes to this Privacy Policy we will publish an updated Privacy Policy on this website. We encourage you to review this website regularly to ensure that you are aware of our current Privacy Policy
Clinical Audit QI Activity Oral Anticoagulants: Their Role
in AF Management
Atrial fibrilation (AF) is cited as the most common sustained cardiac arrhythmia observed in
medical practice. AF is expected to continue to be more prevalent in older age groups, and
in men compared with women.
This audit will allow you to:
Proactively identify AF patients.
Review current management of patients with AF.
Improve understanding of importance of OAC reversal in emergencies.
What is Lorem Ipsum?
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has
been the industry's standard dummy text ever since the 1500s, when an unknown printer took a
galley of type and scrambled it to make a type specimen book. It has survived not only five
centuries, but also the leap into electronic typesetting, remaining essentially unchanged.
It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum
passages, and more recently with desktop publishing software like Aldus PageMaker including
versions of Lorem Ipsum.